Algert Global LLC Tango Therapeutics, Inc. Transaction History

Algert Global LLC

  • $3.72 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$3.76 - $8.06 $8,967 - $19,223
-2,385 Reduced 5.62%
40,088 $158,000
Q4 2022

Feb 13, 2023
BUY
$3.41 - $8.29 $27,450 - $66,734
8,050 Added 23.39%
42,473 $308,000
Q3 2022

Nov 15, 2022
BUY
$3.25 - $5.46 $56,722 - $95,293
17,453 Added 102.85%
34,423 $125,000
Q2 2022

Aug 15, 2022
BUY
$3.86 - $8.01 $65,504 - $135,929
16,970 New
16,970 $77,000

Others Institutions Holding TNGX

# of Institutions
123
Shares Held
91.7M
Call Options Held
3.1K
Put Options Held
1.5K
View Full List

About Tango Therapeutics, Inc.

TNGX Quotes by TradingView
  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $268M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email